Presented on March 26, 2020 by Dr. Janet Pope
During this 1-hour webinar, Dr. Pope will provide a comprehensive overview of how COVID-19 will affect RA/Rheumatology patients and their treatments.
At the end of this session, participants will be able to:
- discuss with their patients the use of DMARDs, biologics, NSAIDs, and steroids during the COVID-19 pandemic
- provide their patients with a course of action if they become infected
- evaluate the use of hydroxychloroquine (HCQ) with rheumatology patients
- evaluate the use of ibuprofen in infected patients
- Medical Expert
This webinar is part of a series supported by unrestricted educational grants from CRA COVID-19 Response Webinar Series supporters.